How close are scientists to finding the vaccine for the new coronary?

Very bad news comes from efforts to develop the vaccine against the new SARS-ComV-2 that caused the Covid-19 pandemic. During today, Professor Robin Shattock, who is leading the team of scientists to develop vaccines at London's Imperial College, acknowledged that the likelihood of vaccine becoming accessible and useful [...]
During today, Professor Robin Shattock, who is leading the team of scientists for the development of vaccine at London's Imperial College, acknowledged that the likelihood of vaccine becoming accessible and useful in September as ministers had hoped were extremely small.
Last month, Professor Sarah Gilber, who is leading another team of scientists in trying to develop vaccines in Great Britain, said that the low rate of information was lowering her team's progress, writes BBC, translates Periscope.
The problem is that a sufficient number of volunteers have to expose the virus to see if the vaccine protects them or not.
If their chances of contacting an infected person are small, it takes longer to demonstrate the efficiency of the candidate vaccine.
We now have essentially a study of the very high security immunogenity that is taking place in the United Kingdom with very little chance of determining efficiency. ”
About 200 teams worldwide are working on the vaccine, and 18 of them are testing human vaccines.
Many experts believe that the major international effort will reach the discovery of an effective vaccine but not before the middle of next year.
And even that wouldn't be guaranteed. /Periscope












